Advertisement
Singapore markets close in 2 hours 53 minutes
  • Straits Times Index

    3,319.24
    +11.34 (+0.34%)
     
  • Nikkei

    39,099.97
    +482.87 (+1.25%)
     
  • Hang Seng

    18,855.29
    -340.31 (-1.77%)
     
  • FTSE 100

    8,370.33
    -46.12 (-0.55%)
     
  • Bitcoin USD

    69,403.56
    -576.52 (-0.82%)
     
  • CMC Crypto 200

    1,510.50
    +7.84 (+0.52%)
     
  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     
  • Dow

    39,671.04
    -201.95 (-0.51%)
     
  • Nasdaq

    16,801.54
    -31.08 (-0.18%)
     
  • Gold

    2,361.70
    -31.20 (-1.30%)
     
  • Crude Oil

    76.95
    -0.62 (-0.80%)
     
  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     
  • FTSE Bursa Malaysia

    1,628.31
    +6.22 (+0.38%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,637.82
    +30.60 (+0.46%)
     

A Struggling Pfizer Looks for Help From a Wall Streeter

A Struggling Pfizer Looks for Help From a Wall Streeter

As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.